ofloxacin has been researched along with Bacteremia in 83 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prophylactic treatment with levofloxacin is an effective and well-tolerated way of preventing febrile episodes and other relevant infection-related outcomes in patients with cancer and profound and protracted neutropenia." | 9.11 | Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. ( Allione, B; Amadori, S; Bucaneve, G; Buelli, M; Cantaffa, R; Cilloni, D; D'Antonio, D; Del Favero, A; Deliliers, GL; Dionisi, MS; Fabbiano, F; Foà, R; Lauria, F; Martinelli, G; Martino, P; Menichetti, F; Micozzi, A; Nosari, AM; Specchia, G; Zuffa, E, 2005) |
| "An open, randomized, multinational, multicentre study was conducted to compare the efficacy, safety and tolerability of levofloxacin 500 mg twice daily with imipenem/cilastatin 1 g iv three-times daily in the treatment of hospitalized adult patients with clinically suspected bacteraemia/ sepsis." | 9.09 | Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial. ( Geddes, A; Härkönen, M; Jacobs, F; Nowotny, I; Schonwald, S; Thaler, M, 1999) |
| "We present a case of a patient who developed seizures shortly after initiating treatment with levofloxacin and to discuss the potential drug-drug interactions related to the inhibition of cytochrome P450 (CYP) 1A2 in this case, as well as in other cases, of levofloxacin-induced seizures." | 8.85 | Seizures associated with levofloxacin: case presentation and literature review. ( Bellon, A; Chacko, RC; Coverdale, JH; Perez-Garcia, G, 2009) |
| "Levofloxacin cures established pneumonic plague when treatment is initiated after the onset of fever in the lethal aerosol-challenged AGM nonhuman primate model, and can be considered for treatment of other forms of plague." | 7.77 | Levofloxacin cures experimental pneumonic plague in African green monkeys. ( Barr, EB; Brasel, TL; Gigliotti, AP; Koster, F; Layton, RC; McDonald, JD; Mega, W, 2011) |
| "THE EFFICACY OF LEVOFLOXACIN: In treating community-acquired pneumonia (CAP) has been assessed during 5 large clinical trials (including 4 controlled randomized trials)." | 7.71 | [Update on the role of levofloxacin in the management of acute community-acquired pneumonia]. ( Bru, JP, 2002) |
| "Despite the use of levofloxacin prophylaxis during the neutropenic period after autologous peripheral blood stem cell transplantation, viridans group (VG) streptococcal bacteremia developed in 6 (16." | 7.71 | Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. ( Khaliq, Y; Litzow, MR; Patel, R; Piper, KE; Razonable, RR; Rouse, MS, 2002) |
| "The authors analyzed 27 breakthrough bacteremias occurring during ofloxacin prophylaxis in afebrile neutropenia over 7 years in 9989 admissions and 979 bacteremic and fungemic episodes in a National Cancer Center in Bratislava, Slovak Republic." | 7.69 | Bacteremia and fungemia occurring during antimicrobial prophylaxis with ofloxacin in cancer patients: risk factors, etiology and outcome. ( Demitrovicova, A; Drgona, L; Helpianska, L; Ilavska, I; Koren, P; Krcmery, V; Kukuckova, E; Lacka, J; Oravcova, E; Pichna, P; Rusnakova, V; Spanik, S; Studena, M; Trupl, J, 1996) |
| "Bacteremia was documented in two patients in the O+R group and six in the control group (p=0." | 5.30 | Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma. ( Brunet, S; Martino, R; Muñoz, L; Sierra, J; Subirà, M; Sureda, A, 1999) |
| "An analysis of subjects with concurrent bacteraemia and either nosocomial pneumonia, complicated intra-abdominal infection or complicated urinary tract infection from six phase 3 clinical trials demonstrated similar cure rates and clearance of bacteraemia in patients treated with doripenem and comparator agents." | 5.17 | Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials. ( Kaniga, K; Lee, M; Redman, R; Rice, DA, 2013) |
| "Prophylactic treatment with levofloxacin is an effective and well-tolerated way of preventing febrile episodes and other relevant infection-related outcomes in patients with cancer and profound and protracted neutropenia." | 5.11 | Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. ( Allione, B; Amadori, S; Bucaneve, G; Buelli, M; Cantaffa, R; Cilloni, D; D'Antonio, D; Del Favero, A; Deliliers, GL; Dionisi, MS; Fabbiano, F; Foà, R; Lauria, F; Martinelli, G; Martino, P; Menichetti, F; Micozzi, A; Nosari, AM; Specchia, G; Zuffa, E, 2005) |
| "An open, randomized, multinational, multicentre study was conducted to compare the efficacy, safety and tolerability of levofloxacin 500 mg twice daily with imipenem/cilastatin 1 g iv three-times daily in the treatment of hospitalized adult patients with clinically suspected bacteraemia/ sepsis." | 5.09 | Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial. ( Geddes, A; Härkönen, M; Jacobs, F; Nowotny, I; Schonwald, S; Thaler, M, 1999) |
| "We present a case of a patient who developed seizures shortly after initiating treatment with levofloxacin and to discuss the potential drug-drug interactions related to the inhibition of cytochrome P450 (CYP) 1A2 in this case, as well as in other cases, of levofloxacin-induced seizures." | 4.85 | Seizures associated with levofloxacin: case presentation and literature review. ( Bellon, A; Chacko, RC; Coverdale, JH; Perez-Garcia, G, 2009) |
| "Recently, the cefixime-ofloxacin combination is approved by Drug Controller General of India to treat typhoid fever." | 3.85 | In vitro efficacy and in silico analysis of cefixime-ofloxacin combination for Salmonella Typhi from bloodstream infection. ( Babu, P; Bakthavatchalam, YD; Doss, CGP; Kumar, DT; Munusamy, E; Ravi, R; Shankar, BA; Tayubi, IA; Thukkaram, B; Veeraraghavan, B, 2017) |
| "Levofloxacin cures established pneumonic plague when treatment is initiated after the onset of fever in the lethal aerosol-challenged AGM nonhuman primate model, and can be considered for treatment of other forms of plague." | 3.77 | Levofloxacin cures experimental pneumonic plague in African green monkeys. ( Barr, EB; Brasel, TL; Gigliotti, AP; Koster, F; Layton, RC; McDonald, JD; Mega, W, 2011) |
| " radiobacter bacteremia treated with levofloxacin." | 3.74 | [A rare cause of catheter-related bacteremia: Rhizobium radiobacter]. ( Görümlü, G; Işikgoz Taşbakan, M; Karabulut, B; Pullukçu, H; Sanli, UA; Sipahi, OR; Tünger, A, 2008) |
| "This paper reports the first case of Haemophilus quentini bacteremia with reduced susceptibility to levofloxacin and resistance to nalidixic acid identified by 16S rRNA sequencing." | 3.73 | Reduced levofloxacin susceptibility and tetracycline resistance in a clinical isolate of Haemophilus quentini identified by 16S rRNA sequencing. ( Ho, PL; Lau, SK; Mak, GC; Tse, CW; Wong, SS, 2005) |
| "In this controlled before and after observational study, moxifloxacin chemoprophylaxis was used during prolonged neutropenia in haemato-oncological patients (period 2; 282 episodes)." | 3.73 | Moxifloxacin prophylaxis in neutropenic patients. ( Bommer, M; Döhner, H; Kern, P; Kern, WV; Marre, R; Reuter, S; Sigge, A; von Baum, H, 2006) |
| "THE EFFICACY OF LEVOFLOXACIN: In treating community-acquired pneumonia (CAP) has been assessed during 5 large clinical trials (including 4 controlled randomized trials)." | 3.71 | [Update on the role of levofloxacin in the management of acute community-acquired pneumonia]. ( Bru, JP, 2002) |
| "We report a case of bacteremia due to Abiotrophia species in a patient with neutropenic fever and cancer who was receiving levofloxacin prophylaxis, followed by empirical therapy with cefepime; the organism was resistant to both antibiotics." | 3.71 | Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates. ( Crawford, S; Jorgensen, JH; McElmeel, ML; Murray, CK; Walter, EA, 2001) |
| "Despite the use of levofloxacin prophylaxis during the neutropenic period after autologous peripheral blood stem cell transplantation, viridans group (VG) streptococcal bacteremia developed in 6 (16." | 3.71 | Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. ( Khaliq, Y; Litzow, MR; Patel, R; Piper, KE; Razonable, RR; Rouse, MS, 2002) |
| "Two patients with acute leukemia developed Escherichia coli bacteremia while receiving oral ofloxacin for antibacterial prophylaxis during profound neutropenia." | 3.69 | Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients. ( Andriof, E; Kern, WV; Markus, A, 1994) |
| "The authors analyzed 27 breakthrough bacteremias occurring during ofloxacin prophylaxis in afebrile neutropenia over 7 years in 9989 admissions and 979 bacteremic and fungemic episodes in a National Cancer Center in Bratislava, Slovak Republic." | 3.69 | Bacteremia and fungemia occurring during antimicrobial prophylaxis with ofloxacin in cancer patients: risk factors, etiology and outcome. ( Demitrovicova, A; Drgona, L; Helpianska, L; Ilavska, I; Koren, P; Krcmery, V; Kukuckova, E; Lacka, J; Oravcova, E; Pichna, P; Rusnakova, V; Spanik, S; Studena, M; Trupl, J, 1996) |
| "The effect of oral therapy with three quinolones (ofloxacin, ciprofloxacin, and pefloxacin) in the prevention of postirradiation bacteremia and mortality was tested in B6D2F1 mice given 9." | 3.68 | Quinolone therapy in the prevention of mortality after irradiation. ( Brook, I; Elliott, TB, 1991) |
| "Febrile neutropenia is an expected complication during treatment of aggressive hematological malignancies and hematopoietic cell transplantation." | 2.73 | The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit. ( Craig, M; Cumpston, AD; Devetten, MP; Ericson, SG; Hobbs, GR; Sarwari, AR, 2007) |
| " This subgroup analysis attempted to compare the safety and efficacy of a short-course levofloxacin regimen with traditional levofloxacin dosing for PSI Class III/IV patients." | 2.72 | Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients. ( Kahn, JB; Khashab, MM; Shorr, AF; Tennenberg, AM; Xiang, JX, 2006) |
| "Both cancer centers differed in prophylactic antibiotic policies." | 2.69 | Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome. ( Foltinova, A; Kaiserova, E; Kiskova, M; Kovacicova, G; Krchnakova, A; Krcmery, V; Krupova, I; Kunova, A; Trupl, J; West, D, 1998) |
| "Ciprofloxacin was therefore superior to the other two fluoroquinolones in preventing infections due to Gram-negative bacteria in this population of neutropenic patients." | 2.67 | Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies. ( Accorsi, P; Betti, S; D'Antonio, D; Dell'Isola, M; Favalli, C; Fioritoni, G; Iacone, A; Parruti, G; Piccolomini, R; Quaglietta, AM, 1994) |
| "The pefloxacin disk assay was approved and implemented by EUCAST (in 2014) and CLSI (in 2015)." | 1.42 | Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica. ( Åhman, J; Kahlmeter, G; Matuschek, E; Petersen, A; Sjölund-Karlsson, M; Skov, R; Stegger, M; Torpdahl, M, 2015) |
| "The empiric treatment of acute pyelonephritis (APN) with third generation cephalosporins (3GC) or fluoroquinolones (FQ) has been challenged by Escherichia coli resistance reported by community surveillance networks." | 1.40 | Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors. ( Caron, F; Choplin-Renard, J; Etienne, M; Pestel-Caron, M; Van Elslande, H, 2014) |
| "Gentamicin resistance was associated with previous administration of a penicillin." | 1.37 | Risk factors for bacteraemia attributable to Pseudomonas aeruginosa resistant to imipenem, levofloxacin, or gentamicin. ( Goto, H; Higaki, M; Honda, K; Ishii, H; Mikura, S; Nakamura, M; Okazaki, M; Tsunoda, T; Wada, H; Watanabe, T; Yasutake, T, 2011) |
| "We describe multiple brain abscesses due to P." | 1.37 | Brain abscesses during Proteus vulgaris bacteremia. ( Bloch, J; Ferriby, D; Legout, L; Lemaire, X; Senneville, E; Yazdanpanah, Y, 2011) |
| "Levofloxacin prophylaxis was associated with fever and a change in antibiotics during neutropenia, but this strategy was not associated with any adverse outcomes." | 1.36 | The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation. ( Corey, L; Fredricks, DN; Frieze, D; Guthrie, KA; Yong, M, 2010) |
| "The in vitro activities of tobramycin and levofloxacin in combination with cefepime were determined by microbroth chequerboard technique against six P." | 1.35 | Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa. ( Otuk, G; Ozbek, B, 2009) |
| "pneumoniae serotype K1, complicated by septic shock and multiple organ dysfunction." | 1.35 | Rapidly fatal bacteremic pneumonia caused by Klebsiella pneumoniae with K1 hypermucoviscosity phenotype in a previously healthy young man receiving levofloxacin treatment. ( Chi, CL; Chuang, TY; Hsueh, PR; Lee, SW; Lin, CJ; Lin, TL; Liu, AY; Wang, JT, 2009) |
| "In this patient, diabetes mellitus and spondylarthritis with HLA-B27 may have played a role in the infection but their imputability remain questionable." | 1.34 | [Pneumonia with bacteremia due to Yersinia enterocolitica in a diabetic patient carrying HLA-B27]. ( Girszyn, N; Kerleau, JM; Lefebvre, S; Levesque, H; Marie, I; Robaday, S, 2007) |
| "Cellulitis is usually caused by organisms such as beta-hemolytic streptococci and Staphylococcus aureus." | 1.32 | Sepsis in a renal transplant recipient due to Citrobacter braakii. ( Agraharkar, ML; Gupta, R; Rauf, SJ; Singh, S; Smith, J, 2003) |
| " The dosing regimen of each drug that yielded serum levels in mice which mimic human therapeutic concentrations of the drugs, were designed." | 1.30 | Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia. ( Bui, KQ; Nicolau, DP; Nightingale, CH; Onyeji, CO; Owens, RC; Quintiliani, R, 1999) |
| "Bacteremia was documented in two patients in the O+R group and six in the control group (p=0." | 1.30 | Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma. ( Brunet, S; Martino, R; Muñoz, L; Sierra, J; Subirà, M; Sureda, A, 1999) |
| " Test fluoroquinolones were administered orally at 1 h (single dose) or at 1 and 3 h (divided dose) postinfection, with 10 infected mice used for each of six concentrations of each fluoroquinolone tested (1 to 40 mg/kg of body weight) in each dosing regimen." | 1.29 | In vivo oral efficacy of levofloxacin for treatment of systemic Pseudomonas aeruginosa infections in a murine model of septicemia. ( Amaratunga, DJ; Barrett, JF; Frosco, MB; Yagel, SK, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 24 (28.92) | 18.2507 |
| 2000's | 39 (46.99) | 29.6817 |
| 2010's | 20 (24.10) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakthavatchalam, YD | 1 |
| Kumar, DT | 1 |
| Tayubi, IA | 1 |
| Shankar, BA | 1 |
| Babu, P | 1 |
| Munusamy, E | 1 |
| Thukkaram, B | 1 |
| Ravi, R | 1 |
| Doss, CGP | 1 |
| Veeraraghavan, B | 1 |
| Rice, DA | 1 |
| Kaniga, K | 1 |
| Lee, M | 1 |
| Redman, R | 1 |
| Assez, N | 1 |
| Mauriaucourt, P | 1 |
| Cuny, J | 1 |
| Goldstein, P | 1 |
| Wiel, E | 1 |
| Saidane, O | 1 |
| Mahmoud, I | 1 |
| Saadi, F | 1 |
| Souayah, A | 1 |
| Zouari, R | 1 |
| Etienne, M | 1 |
| Van Elslande, H | 1 |
| Choplin-Renard, J | 1 |
| Pestel-Caron, M | 1 |
| Caron, F | 1 |
| Skov, R | 1 |
| Matuschek, E | 1 |
| Sjölund-Karlsson, M | 1 |
| Åhman, J | 1 |
| Petersen, A | 1 |
| Stegger, M | 1 |
| Torpdahl, M | 1 |
| Kahlmeter, G | 1 |
| Işikgoz Taşbakan, M | 1 |
| Görümlü, G | 1 |
| Pullukçu, H | 1 |
| Sanli, UA | 1 |
| Sipahi, OR | 1 |
| Karabulut, B | 1 |
| Tünger, A | 1 |
| Brousse, C | 1 |
| Montigny, JP | 1 |
| Marroun, I | 1 |
| Garreau de Loubresse, C | 1 |
| Kahn, JE | 1 |
| Aggarwal, H | 2 |
| Smith, AD | 1 |
| Kuo, PC | 1 |
| Vikraman, DS | 1 |
| Bellon, A | 1 |
| Perez-Garcia, G | 1 |
| Coverdale, JH | 1 |
| Chacko, RC | 1 |
| Guthrie, KA | 1 |
| Yong, M | 1 |
| Frieze, D | 1 |
| Corey, L | 1 |
| Fredricks, DN | 1 |
| Regalado, NG | 1 |
| Martin, G | 1 |
| Antony, SJ | 1 |
| Schmidt-Hieber, M | 1 |
| Stroux, A | 1 |
| Thiel, E | 1 |
| Blau, IW | 1 |
| Eberlein, M | 1 |
| Chahla, MF | 1 |
| Baierlein, SA | 1 |
| Mahon, RT | 1 |
| Ozbek, B | 1 |
| Otuk, G | 1 |
| Chuang, TY | 1 |
| Lin, CJ | 1 |
| Chi, CL | 1 |
| Liu, AY | 1 |
| Lee, SW | 1 |
| Lin, TL | 1 |
| Wang, JT | 1 |
| Hsueh, PR | 1 |
| Kelesidis, T | 1 |
| Dien Bard, J | 1 |
| Humphries, R | 1 |
| Ward, K | 1 |
| Lewinski, MA | 1 |
| Uslan, DZ | 1 |
| Kushnir, L | 1 |
| Conti, D | 1 |
| Gallichio, M | 1 |
| Tobin, E | 1 |
| Gaborieau, V | 1 |
| Weill, FX | 1 |
| Marchou, B | 1 |
| Bloch, J | 1 |
| Lemaire, X | 1 |
| Legout, L | 1 |
| Ferriby, D | 1 |
| Yazdanpanah, Y | 1 |
| Senneville, E | 1 |
| Liu, CY | 1 |
| Lai, YC | 1 |
| Huang, LJ | 1 |
| Yang, YW | 1 |
| Chen, TL | 1 |
| Hsiao, LT | 1 |
| Liu, JH | 1 |
| Gau, JP | 1 |
| Chen, PM | 1 |
| Tzeng, CH | 1 |
| Chiou, TJ | 1 |
| Cuevas, O | 1 |
| Oteo, J | 1 |
| Lázaro, E | 1 |
| Aracil, B | 1 |
| de Abajo, F | 1 |
| García-Cobos, S | 1 |
| Ortega, A | 1 |
| Campos, J | 1 |
| Yee, SB | 1 |
| Hatkin, JM | 1 |
| Dyer, DN | 1 |
| Orr, SA | 1 |
| Pitt, ML | 1 |
| Weiss, S | 1 |
| Kobiler, D | 1 |
| Levy, H | 1 |
| Pass, A | 1 |
| Ophir, Y | 1 |
| Rothschild, N | 1 |
| Tal, A | 1 |
| Schlomovitz, J | 1 |
| Altboum, Z | 1 |
| Layton, RC | 1 |
| Mega, W | 1 |
| McDonald, JD | 1 |
| Brasel, TL | 1 |
| Barr, EB | 1 |
| Gigliotti, AP | 1 |
| Koster, F | 1 |
| Busca, A | 1 |
| Cavecchia, I | 1 |
| Locatelli, F | 1 |
| D'Ardia, S | 1 |
| De Rosa, FG | 1 |
| Marmont, F | 1 |
| Ciccone, G | 1 |
| Baldi, I | 1 |
| Serra, R | 1 |
| Gaido, E | 1 |
| Falda, M | 1 |
| Mikura, S | 1 |
| Wada, H | 1 |
| Okazaki, M | 1 |
| Nakamura, M | 1 |
| Honda, K | 1 |
| Yasutake, T | 1 |
| Higaki, M | 1 |
| Ishii, H | 1 |
| Watanabe, T | 1 |
| Tsunoda, T | 1 |
| Goto, H | 1 |
| Passerini de Rossi, B | 1 |
| Feldman, L | 1 |
| Pineda, MS | 1 |
| Vay, C | 1 |
| Franco, M | 1 |
| Bru, JP | 1 |
| Gupta, R | 1 |
| Rauf, SJ | 1 |
| Singh, S | 1 |
| Smith, J | 1 |
| Agraharkar, ML | 1 |
| Smith, MD | 1 |
| Gradon, JD | 1 |
| Prabhu, RM | 1 |
| Elliott, MA | 1 |
| Patel, R | 2 |
| Gopalachar, A | 1 |
| Akins, RL | 1 |
| Davis, WR | 1 |
| Siddiqui, AA | 1 |
| Bloom, C | 1 |
| Thomson, EC | 1 |
| Main, J | 1 |
| Bucaneve, G | 1 |
| Micozzi, A | 1 |
| Menichetti, F | 1 |
| Martino, P | 1 |
| Dionisi, MS | 1 |
| Martinelli, G | 1 |
| Allione, B | 1 |
| D'Antonio, D | 3 |
| Buelli, M | 1 |
| Nosari, AM | 1 |
| Cilloni, D | 1 |
| Zuffa, E | 1 |
| Cantaffa, R | 1 |
| Specchia, G | 1 |
| Amadori, S | 1 |
| Fabbiano, F | 1 |
| Deliliers, GL | 1 |
| Lauria, F | 1 |
| Foà, R | 1 |
| Del Favero, A | 1 |
| Mak, GC | 1 |
| Ho, PL | 1 |
| Tse, CW | 1 |
| Lau, SK | 1 |
| Wong, SS | 1 |
| Guettrot-Imbert, G | 1 |
| Letranchant, L | 1 |
| Gallot, D | 1 |
| Romaszko, C | 1 |
| Laurichesse, H | 1 |
| Ruotsalainen, E | 2 |
| Järvinen, A | 2 |
| Koivula, I | 1 |
| Kauma, H | 1 |
| Rintala, E | 1 |
| Lumio, J | 1 |
| Kotilainen, P | 1 |
| Vaara, M | 1 |
| Nikoskelainen, J | 1 |
| Valtonen, V | 2 |
| Shorr, AF | 1 |
| Khashab, MM | 1 |
| Xiang, JX | 1 |
| Tennenberg, AM | 1 |
| Kahn, JB | 1 |
| von Baum, H | 1 |
| Sigge, A | 1 |
| Bommer, M | 1 |
| Kern, WV | 2 |
| Marre, R | 1 |
| Döhner, H | 1 |
| Kern, P | 1 |
| Reuter, S | 1 |
| Cattoir, V | 1 |
| Lesprit, P | 1 |
| Lascols, C | 1 |
| Denamur, E | 1 |
| Legrand, P | 1 |
| Soussy, CJ | 1 |
| Cambau, E | 1 |
| Oznur, AK | 1 |
| Ozer, S | 1 |
| Benzonana, NA | 1 |
| Pound, MW | 1 |
| Fulton, KB | 1 |
| Chima, CO | 1 |
| Craig, M | 1 |
| Cumpston, AD | 1 |
| Hobbs, GR | 1 |
| Devetten, MP | 1 |
| Sarwari, AR | 1 |
| Ericson, SG | 1 |
| Girszyn, N | 1 |
| Kerleau, JM | 1 |
| Robaday, S | 1 |
| Lefebvre, S | 1 |
| Marie, I | 1 |
| Levesque, H | 1 |
| Dimopoulos, G | 1 |
| Chang, CY | 1 |
| Lee, YT | 1 |
| Liu, KS | 1 |
| Wang, YL | 1 |
| Tsao, SM | 1 |
| de Cueto, M | 1 |
| Rodríguez, JM | 1 |
| Soriano, MJ | 1 |
| López-Cerero, L | 1 |
| Venero, J | 1 |
| Pascual, A | 1 |
| Kardén-Lilja, M | 1 |
| Kuusela, P | 1 |
| Vuopio-Varkila, J | 1 |
| Virolainen-Julkunen, A | 1 |
| Sarna, S | 1 |
| Amyes, SG | 1 |
| Baird, DR | 1 |
| Crook, DW | 1 |
| Gillespie, SH | 1 |
| Howard, AJ | 1 |
| Oppenhiem, BA | 1 |
| Pedler, SJ | 1 |
| Paull, A | 1 |
| Tompkins, DS | 1 |
| Lawrie, SA | 1 |
| Jensenius, M | 1 |
| Hoel, T | 1 |
| Heier, HE | 1 |
| Markus, A | 1 |
| Andriof, E | 1 |
| Piccolomini, R | 1 |
| Iacone, A | 2 |
| Fioritoni, G | 2 |
| Parruti, G | 1 |
| Betti, S | 2 |
| Quaglietta, AM | 1 |
| Accorsi, P | 1 |
| Dell'Isola, M | 2 |
| Favalli, C | 1 |
| Bow, EJ | 1 |
| Mandell, LA | 2 |
| Louie, TJ | 1 |
| Feld, R | 1 |
| Palmer, M | 1 |
| Zee, B | 1 |
| Pater, J | 1 |
| Plouffe, JF | 1 |
| Bermudez, LE | 1 |
| Kolonoski, P | 1 |
| Young, LS | 1 |
| Spanik, S | 3 |
| Trupl, J | 4 |
| Ilavska, I | 1 |
| Helpianska, L | 1 |
| Drgona, L | 1 |
| Demitrovicova, A | 2 |
| Kukuckova, E | 2 |
| Studena, M | 2 |
| Pichna, P | 2 |
| Oravcova, E | 3 |
| Rusnakova, V | 2 |
| Koren, P | 3 |
| Lacka, J | 3 |
| Krcmery, V | 5 |
| Karachalios, GN | 1 |
| Nasiopoulou, DD | 1 |
| Bourlinou, PK | 1 |
| Reppa, A | 1 |
| Yagel, SK | 1 |
| Barrett, JF | 1 |
| Amaratunga, DJ | 1 |
| Frosco, MB | 1 |
| Kunova, A | 3 |
| Botek, R | 1 |
| Sorkovska, D | 1 |
| Grey, E | 2 |
| Krchnakova, A | 2 |
| Svec, J | 2 |
| Krupova, I | 3 |
| Grausova, S | 2 |
| Stopkova, K | 1 |
| Kralóvicová, K | 1 |
| Kaiserova, E | 1 |
| Foltinova, A | 1 |
| Kovacicova, G | 1 |
| Kiskova, M | 1 |
| West, D | 1 |
| Krupova, Y | 1 |
| Novotny, J | 1 |
| Sabo, A | 1 |
| Mateicka, F | 1 |
| Iwata, M | 1 |
| Tateda, K | 1 |
| Matsumoto, T | 1 |
| Furuya, N | 1 |
| Mizuiri, S | 1 |
| Yamaguchi, K | 1 |
| Onyeji, CO | 1 |
| Bui, KQ | 1 |
| Owens, RC | 1 |
| Nicolau, DP | 1 |
| Quintiliani, R | 1 |
| Nightingale, CH | 1 |
| Muñoz, L | 1 |
| Martino, R | 1 |
| Subirà, M | 1 |
| Brunet, S | 1 |
| Sureda, A | 1 |
| Sierra, J | 1 |
| Limaye, AP | 1 |
| Hooper, CJ | 1 |
| Geddes, A | 1 |
| Thaler, M | 1 |
| Schonwald, S | 1 |
| Härkönen, M | 1 |
| Jacobs, F | 1 |
| Nowotny, I | 1 |
| Hardy, D | 1 |
| Amsterdam, D | 1 |
| Rotstein, C | 1 |
| Guttigoli, A | 1 |
| Zaman, MM | 1 |
| Fogarty, C | 1 |
| Goldschmidt, R | 1 |
| Bush, K | 1 |
| Tauro, S | 1 |
| Dobie, D | 1 |
| Richardson, G | 1 |
| Hastings, M | 1 |
| Mahendra, P | 1 |
| Credito, KL | 1 |
| Jacobs, MR | 1 |
| Appelbaum, PC | 1 |
| Murray, CK | 1 |
| Walter, EA | 1 |
| Crawford, S | 1 |
| McElmeel, ML | 1 |
| Jorgensen, JH | 1 |
| Palau, J | 1 |
| Picón, I | 1 |
| Angel Climent, M | 1 |
| Martí, R | 1 |
| Aznar, E | 1 |
| Carmen Sanjuán, M | 1 |
| Máiquez, J | 1 |
| Rodríguez-Avial, I | 1 |
| Rodríguez-Avial, C | 1 |
| Picazo, JJ | 1 |
| Razonable, RR | 1 |
| Litzow, MR | 1 |
| Khaliq, Y | 1 |
| Piper, KE | 1 |
| Rouse, MS | 1 |
| Ross, JJ | 1 |
| Worthington, MG | 1 |
| Gorbach, SL | 1 |
| Göker, K | 1 |
| Güvener, O | 1 |
| Pizzigallo, E | 1 |
| Piergallini, A | 1 |
| Di Gianfilippo, R | 1 |
| Olioso, P | 1 |
| Torlontano, G | 1 |
| Gür, D | 1 |
| Kocagöz, T | 1 |
| Akalin, HE | 1 |
| Rozdzinski, E | 1 |
| Kirchner, S | 1 |
| Kern, W | 1 |
| Brook, I | 1 |
| Elliott, TB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Feasibility Study of the Use of Intermediate Doses of Cytarabine Associated With Autologous Hematopoietic Stem Cells as Consolidation Treatment of Young Adults With Low- or Intermediate-risk de Novo Acute Myeloid Leukemia[NCT03023384] | 547 participants (Anticipated) | Observational [Patient Registry] | 2016-12-31 | Recruiting | |||
| [NCT00548002] | 430 participants (Actual) | Observational | 1999-01-31 | Completed | |||
| Gemifloxacin Versus Ciprofloxacin Versus Rifampicin in Treatment of Rhinoscleroma[NCT03326050] | Early Phase 1 | 60 participants (Anticipated) | Interventional | 2018-02-28 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for ofloxacin and Bacteremia
| Article | Year |
|---|---|
[Fever and jaundice... and if it was a leptospirosis. About a case of L. interrogans icterohaemorrhagiae in Northern France].
Topics: Acute Kidney Injury; Adult; Amoxicillin-Potassium Clavulanate Combination; Animal Husbandry; Animals | 2013 |
Seizures associated with levofloxacin: case presentation and literature review.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cytochrome | 2009 |
Bacteremia due to Comamonas species possibly associated with exposure to tropical fish.
Topics: Administration, Oral; Aged; Aged, 80 and over; Animals; Animals, Domestic; Anti-Infective Agents; Ba | 2003 |
Treatment of tularemia with fluoroquinolones: two cases and review.
Topics: Adult; Anti-Infective Agents; Bacteremia; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Tulare | 1999 |
12 trials available for ofloxacin and Bacteremia
| Article | Year |
|---|---|
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem | 2013 |
Antibacterial prophylaxis with levofloxacin in patients after allogeneic stem cell transplantation and neutrophil reconstitution: results from a double-blinded, placebo-controlled phase III trial and overview of recent clinical practice.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Double-Blind Method; Female; Humans; Leukemia, Myelo | 2010 |
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacte | 2005 |
Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Chi-Square Distribution; Drug Therapy, Combination; | 2006 |
Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Community-Acquired Infections; Drug Administration Schedule | 2006 |
The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Drug Administration Schedule; Drug Resist | 2007 |
Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Case-Control Studies; Electro | 2008 |
Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
Topics: Adult; Aged; Agranulocytosis; Anti-Infective Agents; Bacteremia; Bacterial Infections; Ciprofloxacin | 1994 |
Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group.
Topics: Adult; Aged; Anti-Infective Agents; Antineoplastic Agents; Bacteremia; Colony Count, Microbial; Fema | 1996 |
Treatment of acute biliary tract infections with ofloxacin: a randomized, controlled clinical trial.
Topics: Anti-Infective Agents; Bacteremia; Ceftriaxone; Cephalosporins; Cholangitis; Cholecystitis; Escheric | 1996 |
Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.
Topics: Adult; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; A | 1998 |
Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Cilastatin; Cilastati | 1999 |
67 other studies available for ofloxacin and Bacteremia
| Article | Year |
|---|---|
In vitro efficacy and in silico analysis of cefixime-ofloxacin combination for Salmonella Typhi from bloodstream infection.
Topics: Anti-Bacterial Agents; Bacteremia; Cefixime; Humans; India; Microbial Sensitivity Tests; Ofloxacin; | 2017 |
[Spondylodiscitis and Lactococcus cremoris endocarditis].
Topics: Aged; Animals; Anti-Bacterial Agents; Bacteremia; Braces; Cattle; Combined Modality Therapy; Disciti | 2013 |
Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Catchment Area, Heal | 2014 |
Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.
Topics: Anti-Bacterial Agents; Bacteremia; Base Sequence; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; | 2015 |
[A rare cause of catheter-related bacteremia: Rhizobium radiobacter].
Topics: Adult; Agrobacterium tumefaciens; Anti-Bacterial Agents; Bacteremia; Bone Neoplasms; Catheterization | 2008 |
[Charcot's disease of the lumbosacral joint in spinal cord injury: a case report].
Topics: Accidents, Traffic; Adult; Arthropathy, Neurogenic; Bacteremia; Diagnostic Errors; Discitis; Epidura | 2008 |
Streptococcus equi primary bacteremia in a hepatitis-C cirrhotic patient.
Topics: Anti-Bacterial Agents; Bacteremia; Hepatitis C; Humans; Liver Cirrhosis; Male; Middle Aged; Ofloxaci | 2009 |
The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Ceftazidime; Disease-Free Survival; Drug Resistance | 2010 |
Acinetobacter lwoffii: bacteremia associated with acute gastroenteritis.
Topics: Acinetobacter; Acinetobacter Infections; Acute Disease; Anti-Bacterial Agents; Bacteremia; Community | 2009 |
A fall in Ghana.
Topics: Accidental Falls; Adult; Anti-Bacterial Agents; Back Pain; Bacteremia; Diagnosis, Differential; Ghan | 2009 |
Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Dose-Response Relationship, Drug; Drug | 2009 |
Rapidly fatal bacteremic pneumonia caused by Klebsiella pneumoniae with K1 hypermucoviscosity phenotype in a previously healthy young man receiving levofloxacin treatment.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacteremia; Bacterial Capsules; Bacterial Typing Techniq | 2009 |
First report of treatment of Anaerobiospirillum succiniciproducens bloodstream infection with levofloxacin.
Topics: Aged, 80 and over; Anaerobiospirillum; Anti-Bacterial Agents; Bacteremia; DNA, Bacterial; DNA, Ribos | 2010 |
A case of Campylobacter jejuni bacteremia in a renal transplant patient.
Topics: Anti-Bacterial Agents; Bacteremia; Campylobacter Infections; Campylobacter jejuni; Diarrhea; Female; | 2010 |
[A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Topics: Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; | 2010 |
Brain abscesses during Proteus vulgaris bacteremia.
Topics: Anti-Bacterial Agents; Antiphospholipid Syndrome; Bacteremia; Brain; Brain Abscess; Ceftriaxone; Com | 2011 |
Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cohort Studi | 2011 |
Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Aza Compo | 2011 |
Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.
Topics: Aerosols; Animals; Anthrax; Anti-Bacterial Agents; Antigens, Bacterial; Bacillus anthracis; Bacterem | 2010 |
Antibiotics cure anthrax in animal models.
Topics: Animals; Anthrax; Anthrax Vaccines; Anti-Bacterial Agents; Antigens, Bacterial; Bacillus anthracis; | 2011 |
Levofloxacin cures experimental pneumonic plague in African green monkeys.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Chlorocebus aethiops; Disease Models, Animal; Infusions, | 2011 |
Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Candida; Candida | 2012 |
Risk factors for bacteraemia attributable to Pseudomonas aeruginosa resistant to imipenem, levofloxacin, or gentamicin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Child; Child, Prescho | 2011 |
Comparative in vitro efficacies of ethanol-, EDTA- and levofloxacin-based catheter lock solutions on eradication of Stenotrophomonas maltophilia biofilms.
Topics: Anti-Bacterial Agents; Argentina; Bacteremia; Biofilms; Catheter-Related Infections; Catheters, Indw | 2012 |
[Update on the role of levofloxacin in the management of acute community-acquired pneumonia].
Topics: Acute Disease; Anti-Infective Agents; Bacteremia; Community-Acquired Infections; Humans; Levofloxaci | 2002 |
Sepsis in a renal transplant recipient due to Citrobacter braakii.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Bacteremia; Cellulitis; Citrobacter freundi | 2003 |
Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Female; Fluoroquinolones; Hematopoi | 2004 |
Urinary tract infection caused by Aerococcus viridans, a case report.
Topics: Aged; Aged, 80 and over; Bacteremia; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; | 2004 |
An elderly lady with sudden blindness and a sore foot.
Topics: Administration, Topical; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blindness; Ceftriaxon | 2006 |
Reduced levofloxacin susceptibility and tetracycline resistance in a clinical isolate of Haemophilus quentini identified by 16S rRNA sequencing.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Mul | 2005 |
[Multiorgan failure due to gonococcal peritonitis in an HIV-HCV co-infected female patient].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ascites; Bacteremia; Carcinoma, Hepatocellular | 2004 |
Moxifloxacin prophylaxis in neutropenic patients.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteremia; Clostridioides difficile; | 2006 |
In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; DNA Topoisomerases; Drug Resistance; Escherichia coli; Esch | 2006 |
[Antibiotic resistance in Streptococcus pneumoniae strains isolated from sterile body sites].
Topics: Anti-Bacterial Agents; Bacteremia; Cerebrospinal Fluid; Dacryocystitis; Drug Resistance, Bacterial; | 2006 |
Successful treatment of Klebsiella rhinoscleromatis bacteremia with levofloxacin.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Female; Humans; Klebsiella Infections; Klebsiella pneumonia | 2007 |
[Pneumonia with bacteremia due to Yersinia enterocolitica in a diabetic patient carrying HLA-B27].
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Diabetes Mellitus, Type 2; HLA-B27 Antigen; Humans; Male; O | 2007 |
Antibiotics selection for bacteremic pneumonia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Dose-Response Relationship, Drug; Fluoroquinolones; | 2007 |
Chromobacterium violaceum infection in Taiwan: a case report and literature review.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Chromobacterium; Female; Gram-Negative Bacteri | 2007 |
Fatal levofloxacin failure in treatment of a bacteremic patient infected with Streptococcus pneumoniae with a preexisting parC mutation.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacteria | 2008 |
A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Topics: Anti-Infective Agents; Bacteremia; Bacteria; Bacteriuria; Cefotaxime; Ceftazidime; Cefuroxime; Cepha | 1994 |
[Yersinia enterocolitica septicemia after blood transfusion].
Topics: Aged; Bacteremia; Humans; Male; Ofloxacin; Transfusion Reaction; Yersinia enterocolitica; Yersinia I | 1995 |
Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Infective Agents; Bacteremia; Drug Resistance, Micr | 1994 |
Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Franklin County Pneumonia Study Group.
Topics: Anti-Infective Agents; Bacteremia; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin | 1996 |
Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Colony Count, Microbial; Drug Com | 1996 |
Bacteremia and fungemia occurring during antimicrobial prophylaxis with ofloxacin in cancer patients: risk factors, etiology and outcome.
Topics: Bacteremia; Disease Outbreaks; Fungemia; Humans; Incidence; Microbial Sensitivity Tests; Neoplasms; | 1996 |
In vivo oral efficacy of levofloxacin for treatment of systemic Pseudomonas aeruginosa infections in a murine model of septicemia.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Female; Levofloxaci | 1996 |
Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Dru | 1997 |
Resistance pattern of 2816 isolates isolated from 17631 blood cultures and etiology of bacteremia and fungemia in a single cancer institution.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteremia; Cephal | 1997 |
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Stu | 1998 |
Primary Shewanella alga septicemia in a patient on hemodialysis.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Drug Therapy, Combination; Escherichia coli; Female; G | 1999 |
Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia.
Topics: Acute Kidney Injury; Administration, Cutaneous; Animals; Anti-Infective Agents; Bacteremia; Ciproflo | 1999 |
Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bact | 1999 |
Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Fluoroquinol | 2000 |
Bacteremia and possible endocarditis caused by Moraxella phenylpyruvica.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cefotaxime; Cephalospor | 2000 |
Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteremia; Drug Resistance | 2000 |
Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Transplantation; Carm | 2000 |
Anti-anaerobic activity of levofloxacin alone and combined with clindamycin and metronidazole.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria, Anaerobic; Clindamycin; Drug Combinations; Drug Synergi | 2000 |
Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Drug Resistance, Microbial; Fever; Gram | 2001 |
[Infection in patients with neutropenia that undergo an autologous peripheral blood stem cell transplant due to breast cancer].
Topics: Acyclovir; Adult; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Pro | 2001 |
[In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Drug Resistance; Drug Resistance, M | 2001 |
Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis.
Topics: Adult; Aged; Anti-Infective Agents; Bacteremia; Chemoprevention; Drug Resistance, Bacterial; Female; | 2002 |
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
Topics: Aged; Anti-Infective Agents; Bacteremia; Drug Resistance, Bacterial; Fatal Outcome; Humans; Levoflox | 2002 |
Antibacterial effects of ofloxacin, clindamycin and sultamicillin on surgical removal of impacted third molars.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Clindamycin; Dental Care for Disabled; Drug Th | 1992 |
Occurrence of bacteremia in hematologic patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Bone Marrow Transplantation; Catheterization; Ciprofloxacin; Fe | 1992 |
[In vitro activity of various antibiotic agents against gram-negative nosocomial bacteremia pathogens].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; | 1992 |
Removal of the antibacterial activity of trimethoprim-sulfamethoxazole, ofloxacin and zidovudine by BACTEC resin-containing blood culture medium.
Topics: Bacteremia; Bacteria; Culture Media; Humans; Ofloxacin; Piperacillin; Resins, Plant; Trimethoprim, S | 1991 |
Quinolone therapy in the prevention of mortality after irradiation.
Topics: Animals; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Cobalt Radioisotopes; Female; Gamma Rays; | 1991 |